Old Ocean Mold

Fungi in 100 million year-old seafloor sediments could possess novel antibiotics.

Written byBeth Marie Mole
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

microscopic image of Penicillium sp.Wikimedia, Y_tambeDigging 127 meters below the Pacific Ocean floor, into 100 million year-old sediments, researchers have discovered flourishing fungi, including some that belong to the genus Penicillium—the source of penicillin. The discovery, reported last week (December 6) at the meeting of the American Geophysical Union in San Francisco, California, provides hope of finding novel antibiotics deep below the ocean, as well as understanding how life can thrive in such a nutrient-poor environment.

“[The study] extends what we understand about the limits of life on the planet,” molecular geo­microbiologist Heath Mills of the Texas A&M University in College Station, who studied the fungi, told Nature. Moreover, “this is adding a new family of potential drugs,” added biogeochemist Brandi Reese, of the University of Southern California in Los Angeles, who collaborated with Mills on the study.

The researchers isolated the fungi from sediments collected on a South Pacific drilling expedition in 2010. Back in the lab, they found genetic sequences from at least eight groups of fungi, and were able to grow four fungi from the sediments.

Mills and Reese hypothesize that the fungi may play critical roles in the deep-sea sediment ecosystems, such as deconstructing organic matter in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies